Cargando…

Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation

Adoptive cell therapy (ACT) of autologous tumor infiltrating lymphocytes (TIL) is an effective immunotherapy for patients with solid tumors, yielding objective response rates of around 40% in refractory patients with metastatic melanoma. Most clinical centers utilize bulk, randomly isolated TIL from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seliktar-Ofir, Sivan, Merhavi-Shoham, Efrat, Itzhaki, Orit, Yunger, Sharon, Markel, Gal, Schachter, Jacob, Besser, Michal J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641376/ https://www.ncbi.nlm.nih.gov/pubmed/29067023 http://dx.doi.org/10.3389/fimmu.2017.01211

Ejemplares similares

Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy
por: Yunger, Sharon, et al.
Publicado: (2019)

Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides
por: Besser, Hanan, et al.
Publicado: (2019)

Development of Allogeneic NK Cell Adoptive Transfer Therapy in Metastatic Melanoma Patients: In Vitro Preclinical Optimization Studies
por: Besser, Michal J., et al.
Publicado: (2013)

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy
por: Nissani, Abraham, et al.
Publicado: (2021)

Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex
por: Greenberg, Eyal, et al.
Publicado: (2014)

Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy
por: Ortenberg, R., et al.
Publicado: (2015)

A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme
por: Galore-Haskel, Gilli, et al.
Publicado: (2015)

Immune co-culture cell microarray – a feasible tool for high-throughput functional investigation of lymphocyte–cancer interactions
por: Baruch, Erez Nissim, et al.
Publicado: (2020)

Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs
por: Greenberg, Eyal, et al.
Publicado: (2011)

SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells
por: Ashkenazi, Shira, et al.
Publicado: (2016)

Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens
por: Kalaora, Shelly, et al.
Publicado: (2016)

Novel Anti-Melanoma Immunotherapies: Disarming Tumor Escape Mechanisms
por: Sapoznik, Sivan, et al.
Publicado: (2012)

Focus on Adoptive T Cell Transfer Trials in Melanoma
por: Hershkovitz, Liat, et al.
Publicado: (2010)

Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients
por: Itzhaki, Orit, et al.
Publicado: (2020)

Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma
por: Itzhaki, Orit, et al.
Publicado: (2013)

Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
por: Rozenbaum, Meir, et al.
Publicado: (2020)

Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy
por: Zhu, Yicheng, et al.
Publicado: (2021)

Genetic Modification of Tumor-Infiltrating Lymphocytes via Retroviral Transduction
por: Weinstein-Marom, Hadas, et al.
Publicado: (2021)

Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
por: Wang, Zhidong, et al.
Publicado: (2020)

Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells()()
por: Kfir-Elirachman, Karin, et al.
Publicado: (2018)

Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal
por: Bianchi, Valentina, et al.
Publicado: (2020)

Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies
por: Kast, Florian, et al.
Publicado: (2021)

Adoptive neoantigen-reactive T cell therapy: improvement strategies and current clinical researches
por: Huang, Ruichen, et al.
Publicado: (2023)

Membrane anchored IL-18 linked to constitutively active TLR4 and CD40 improves human T cell antitumor capacities for adoptive cell therapy
por: Blokon-Kogan, Dayana, et al.
Publicado: (2022)

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Lauss, Martin, et al.
Publicado: (2017)

Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma
por: Wei, Teng, et al.
Publicado: (2021)

CEACAM1 Promotes Melanoma Cell Growth through Sox-2()()
por: Ortenberg, Rona, et al.
Publicado: (2014)

KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors
por: Lu, Dan, et al.
Publicado: (2023)

miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1
por: Cohen, Ronit, et al.
Publicado: (2015)

Shared cancer neoantigens: Making private matters public
por: Klebanoff, Christopher A., et al.
Publicado: (2018)

Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
por: Wu, Daichao, et al.
Publicado: (2020)

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Lauss, Martin, et al.
Publicado: (2020)

Identification of Shared Neoantigens in BRCA1-Related Breast Cancer
por: Ruangapirom, Lucksica, et al.
Publicado: (2022)

Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells
por: Markel, Gal, et al.
Publicado: (2009)

Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients
por: Sivan, Sapoznik, et al.
Publicado: (2012)

Is there a future for adoptive cell transfer in melanoma patients?
por: Besser, Michal J
Publicado: (2013)

Neoantigen-reactive CD8(+) T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
por: Kristensen, Nikolaj Pagh, et al.
Publicado: (2022)

Determination, Separation and Application of (137)Cs: A Review
por: Cao, Yiyao, et al.
Publicado: (2022)

Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma
por: Galore-Haskel, Gilli, et al.
Publicado: (2017)

Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell Malignancies
por: Beider, Katia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_joqenso3nbdbfvaru0e131u6st